S100A4 and osteoarthritis: S100A4 has been found to be upregulated in osteoarthritis chondrocytes (also in our study log2FC = 0.8, P = 1.9 × 10−15) and has been proposed to be a transcriptional regulator of MMP13, which is a key metalloprotease of extracellular matrix degradation (65).